Investigating the Safety and Clinical Performance of Eight iVascular Devices for Endovascular Intervention in Renal, Iliac or Femoral Arteries

Inclusion Criteria: * Corresponding to the CE-mark indications/contra-indications and according to the IFU of the device. * Patient is \>18 years old. * Patient understands the nature of the procedure and provides written informed consent prior to enrollment in the study. * Target lesion(s) is/are located in renal, iliac or femoral arteries. * Patient is eligible for treatment with the Oceanus 18 Balloon Dilatation Catheter and/or the Oceanus 35 Balloon Dilatation Catheter and/or the Luminor 18 Drug Coated Balloon and/or the Luminor 35 Drug Coated Balloon and/or the Restorer Peripheral Stent System and/or the iVolution pro Peripheral Self-Expanding Stent System and/or the iCover Covered Peripheral Stent System and/or the Sergeant Peripheral Support Catheter as described in IFU for each device. Exclusion Criteria: * Anatomy or size of vessels that will not allow appropriate usage of the investigational devices, following IFU of the investigational devices. * Known contraindication and/or allergy to (a component of) an investigational device. * Pregnant women and women with childbearing potential not taking adequate contraceptives or currently breastfeeding. * Life expectancy of less than 12 months. * Any planned surgical intervention/procedure within 30 days after the study procedure. * Any patient considered to be hemodynamically unstable at onset of the procedure.